Qtaxem 25 mg/ml
Qtaxem 25 mg/ml is a medicine authorised by Swissmedic under authorisation number 70675. The authorisation holder is Exeltis Suisse SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 August 2026 and the authorisation is limited until 05 August 2031. ATC code N05AH04 places the medicine in the group Psycholeptics.
| Authorisation number | 70675 |
|---|---|
| Name | Qtaxem 25 mg/ml |
| Full name | Qtaxem 25 mg/ml, Suspension zum Einnehmen |
| Authorisation holder | Exeltis Suisse SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05AH04 |
| First authorisation | 06 August 2026 |
| Authorisation validity | 05 August 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Qtaxem 25 mg/ml, Suspension zum Einnehmen | B | 06 August 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | ml | N05AH04 | 01.05.0. | B |
| 2 | 120 | ml | N05AH04 | 01.05.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Qtaxem 25 mg/ml authorised in Switzerland?
Yes. Qtaxem 25 mg/ml is authorised by Swissmedic under authorisation number 70675, data as of 01 September 2026. The authorisation is limited until 05 August 2031.
Which dispensing category does Qtaxem 25 mg/ml have?
Qtaxem 25 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Qtaxem 25 mg/ml?
The authorisation holder is Exeltis Suisse SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.